China Extracorporeal Life Support Registry

NCT04158479 · tracked via the Priya Life Science China tracker

Sponsor

Beijing Anzhen Hospital

Phase

Observational

Started

2017-01-01

Last updated

2024-04-09

Condition(s) studied

Cardiogenic ShockCardiac ArrestHeart FailureAcute Respiratory Distress SyndromeAcute Respiratory Failure

Investigational drug(s) / intervention(s)

ECMO

ECMO: ECMO for circulatory and/or respiratory support

Study summary

Extracorporeal life support (ECLS), also known as extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective cardiac and respiratory support to patients with lungs and/or heart failure. There was a growth in ECLS cases, centers, and center scale in China during the past decade.

This multi-center registry was conducted by Chinese Society of Extracorporeal Life Support. The objectives were to investigate China statistics of ECLS and to evaluate the short-term and long-term outcomes of patients with ECLS.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients receiving ECMO for circulatory and/or respiratory support Exclusion Criteria: * Refusal of consent

Primary outcome measure(s)

All-cause mortality — 30 days

Trial sites (1)

Facility	City	Region	Status
Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University	Beijing	Beijing Municipality	Recruiting

More Beijing Anzhen Hospital trials in China

Helium-free Magnetocardiography Guided Therapy for Stable Coronary Artery Disease - A Randomized Controlled Trial Recruiting

Early Intra-aortic Balloon Pump Use After Venoarterial Extracorporeal Membrane Oxygenation Recruiting

Wellbeing and Survival Improvement With Event Reduction by Ablation for Atrial Fibrillation in the Very Elderly Recruiting

Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke Recruiting

Photoplethysmography (PPG) Algorithm With Smartwatch in Evaluation of Atrial Fibrillation Burden Starting soon

Other trials for the same condition

A Pivotal Clinical Trial of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes Injection (HiCM-188) for the Treatment of Advanced Heart Failure(NYHA III-IV) Recruiting

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity Recruiting

Target-directed Management of Cerebral Oxygenation in Patients After Receiving ECPR Recruiting

Artificial Intelligence in Detecting Cardiac Function Enrolling by invitation

Clinical Study of Impact of Different Pacing Site in Patients Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04158479 on ClinicalTrials.gov ↗ ← All trials in China